Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Zeiser

Showing results (151-160 of 373) with videos related to

Pageof 38
Sort By:
Oncotarget|November 12, 2016
CXCR4 antagonists suppress small cell lung cancer progressionSanaz Taromi, Gian Kayser, Julie Catusse, et al.
European Journal of Immunology|December 23, 2018
High-dimensional single-cell proteomics analysis identifies immune checkpoint signatures and therapeutic targets in ulcerative colitisSebastian Fuchs, Nadia Sawas, Nicolas Staedler, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 17, 2026
Symptom distress evolution over the first year after allogeneic stem cell transplantation - a prospective observational sub-study of the SMILe projectAnja Schmid, Janette Ribaut, Sabina M De Geest, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 18, 2012
High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosisDimitrios Mougiakakos, Riki Okita, Takashi Ando, et al.
Haematologica|October 15, 2020
Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myelomaSandra Maria Dold, Veronika Riebl, Dagmar Wider, et al.
Cellular Immunology|June 15, 2012
Rap1a deficiency modifies cytokine responses and MAPK-signaling in vitro and impairs the in vivo inflammatory responseAnnette Dorn, Anna Zoellner, Marie Follo, et al.
Blood|October 31, 2007
Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cellsRobert Zeiser, Dennis B Leveson-Gower, Elizabeth A Zambricki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2008
Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantationWilfried Reichardt, Christoph Dürr, Dominik von Elverfeldt, et al.
Blood|February 24, 2023
Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysisGerard Socié, Dietger Niederwieser, Nikolas von Bubnoff, et al.
Oncotarget|July 9, 2016
Loss of LSR affects epithelial barrier integrity and tumor xenograft growth of CaCo-2 cellsBernd A Czulkies, Justin Mastroianni, Lisa Lutz, et al.
Pageof 38

Showing results (151-160 of 373) with videos related to

Sort By:
Pageof 38
Oncotarget|November 12, 2016
CXCR4 antagonists suppress small cell lung cancer progressionSanaz Taromi, Gian Kayser, Julie Catusse, et al.
European Journal of Immunology|December 23, 2018
High-dimensional single-cell proteomics analysis identifies immune checkpoint signatures and therapeutic targets in ulcerative colitisSebastian Fuchs, Nadia Sawas, Nicolas Staedler, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 17, 2026
Symptom distress evolution over the first year after allogeneic stem cell transplantation - a prospective observational sub-study of the SMILe projectAnja Schmid, Janette Ribaut, Sabina M De Geest, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 18, 2012
High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosisDimitrios Mougiakakos, Riki Okita, Takashi Ando, et al.
Haematologica|October 15, 2020
Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myelomaSandra Maria Dold, Veronika Riebl, Dagmar Wider, et al.
Cellular Immunology|June 15, 2012
Rap1a deficiency modifies cytokine responses and MAPK-signaling in vitro and impairs the in vivo inflammatory responseAnnette Dorn, Anna Zoellner, Marie Follo, et al.
Blood|October 31, 2007
Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cellsRobert Zeiser, Dennis B Leveson-Gower, Elizabeth A Zambricki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2008
Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantationWilfried Reichardt, Christoph Dürr, Dominik von Elverfeldt, et al.
Blood|February 24, 2023
Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysisGerard Socié, Dietger Niederwieser, Nikolas von Bubnoff, et al.
Oncotarget|July 9, 2016
Loss of LSR affects epithelial barrier integrity and tumor xenograft growth of CaCo-2 cellsBernd A Czulkies, Justin Mastroianni, Lisa Lutz, et al.
Pageof 38